News Vivek Ramaswamy confirms bid for US presidency Biotech entrepreneur has launched his Vivek2024 campaign with an attack on the 'woke left'.
News French court overturns €444m fine for Novartis, Roche Says companies did not abuse a market position to push Lucentis over off-label Avastin in AMD.
News Daiichi Sankyo wins round in Enhertu patent dispute US PTO has agreed to take another look at whether Seagen's '039 patent is valid.
News CMS eyes lower prices for drugs with accelerated approval Approach could cut medicine costs and curb delays in confirmatory trials, says agency
News Changing Faces: Agency and investor hires in Dec and Jan December and January had their share of hires in marketing and comms, and an investor hire too.
News Changing Faces: Pharma-adjacent hires in Dec ’22 and Jan ’23 December and January also saw hires in digital health companies and pharm-adjacent industries
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
